Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amikacin vs ertapenem for complicated urinary tract infections caused by ceftriaxone-resistant Enterobacteriaceae
TCTR20190924001Not yet recruiting
- Sponsor
- The College of Pharmacotherapy of Thailand
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in complicated urinary tract infection (cUTI) and urinary tract infection (UTI) comparing Amikacin definitive therapy with Ertapenem definitive therapy (2 arms). Planned start Sep 2019; status: not yet recruiting.
02
Drugs
amikacinertapenem
03
Conditions
complicated urinary tract infection (cUTI)urinary tract infection (UTI)
Beyond the preview
Go deeper on TCTR20190924001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190924001.